Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

IMS 2023 | Challenges with selecting therapy after failure of frontline treatments in R/R multiple myeloma

In this video, Noopur Raje, MD, Massachusetts General Hospital, Boston, MA, discusses the challenges faced by clinicians when selecting therapies for patients with multiple myeloma who have relapsed after frontline therapy. Dr Raje also elaborates on the optimal sequencing of T-cell directed immunotherapies and their potential inclusion in the frontline setting. This interview took place at the 20th International Myeloma Society (IMS) Annual Meeting, held in Athens, Greece.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.